Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMG-CoA/Chol ointment for porokeratosis
jRCTs031190203Completed
- Sponsor
- Niigata University
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in porokeratosis comparing Atorvastatin/cholesterol ointment with Placebo ointment (2 arms). Primary endpoint: Improvement rate of hyperkeratosis. Started Mar 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
porokeratosis
Beyond the preview
Go deeper on jRCTs031190203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190203.